Genetic and modifiable risk factors contributing to cisplatin-induced toxicities

MR Trendowski, O El Charif, PC Dinh Jr, LB Travis… - Clinical Cancer …, 2019 - AACR
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target
toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent, which has …
被引用次数：101 相关文章

Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.

MR Trendowski, O El Charif, PC Dinh Jr… - … Cancer Research: an …, 2018 - europepmc.org
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target
toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent that has potent …

Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities

MR Trendowski, O El Charif, PC Dinh, LB Travis… - Clinical Cancer …, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Effective administration of traditional cytotoxic
chemotherapy is often limited by off-target toxicities. This clinical dilemma is epitomized by …

Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities

MR Trendowski, O El Charif… - … : an official journal …, 2019 - pubmed.ncbi.nlm.nih.gov
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target
toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent, which has …
[PDF] iupui.edu

[PDF][PDF] Genetic and Modifiable Risk Factors Contributing to Cisplatin-Induced Toxicities

MR Trendowski, O El Charif, PC Dinh Jr, LB Travis… - 2019 - scholarworks.iupui.edu
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target
toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent that has potent …
[HTML] nih.gov

[HTML][HTML] Genetic and Modifiable Risk Factors Contributing to Cisplatin-Induced Toxicities

MR Trendowski, O El Charif, PC Dinh Jr… - … cancer research: an …, 2019 - ncbi.nlm.nih.gov
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target
toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent that has potent …
[PDF] researchgate.net

[PDF][PDF] Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities

MR Trendowski, O El Charif, PCD Jr, LB Travis… - 2018 - researchgate.net
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target
toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent, which has …
[PDF] core.ac.uk

[PDF][PDF] Genetic and Modifiable Risk Factors Contributing to Cisplatin-Induced Toxicities

MR Trendowski, O El Charif, PC Dinh Jr, LB Travis… - Clin Cancer Res, 2019 - core.ac.uk
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target
toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent that has potent …

Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities.

MR Trendowski, O El Charif, PC Dinh Jr… - … Cancer Research: an …, 2018 - europepmc.org
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target
toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent that has potent …
[PDF] iupui.edu

[PDF][PDF] Genetic and Modifiable Risk Factors Contributing to Cisplatin-Induced Toxicities

MR Trendowski, O El Charif, PC Dinh Jr… - Clin Cancer …, 2019 - scholarworks.iupui.edu
Effective administration of traditional cytotoxic chemotherapy is often limited by off-target
toxicities. This clinical dilemma is epitomized by cisplatin, a platinating agent that has potent …